GlassScriptPhysician profile
James C Jensen
NPI 1538267547
$3,946.18
in general payments reported to CMS, 2019-2025
24 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,652 · 2020: $184 · 2021: $125 · 2022: $127 · 2023: $430 · 2024: $261 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.30 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,953.34 | 2019-2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $729.43 | 2019-2025 | Lynparza, Imfinzi |
| Myriad Genetic Laboratories, INC. | $158.94 | 2023-2024 | Precisetumor, Mychoice Cdx, Prolaris |
| Boston Scientific Corporation | $133.79 | 2019-2022 | |
| Bard Access Systems, INC. | $118.91 | 2019 | |
| Ambu INC. | $104.33 | 2023 | |
| Seagen INC. | $100.41 | 2022-2023 | Tivdak |
| Coopersurgical, INC. | $95.00 | 2019 | |
| Genentech USA, INC. | $90.70 | 2019 | |
| Clovis Oncology, INC. | $78.85 | 2019 | |
| Tesaro, INC. | $73.31 | 2019 | |
| Ethicon US, LLC | $49.81 | 2019 | |
| Convatec INC. | $37.54 | 2023 | |
| Janssen Biotech, INC. | $30.91 | 2023 | |
| Merck Sharp & Dohme LLC | $23.98 | 2025 | Lynparza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $22.94 | 2023 | |
| Baxter Healthcare | $22.41 | 2023 | Tisseel |
| Bayer Healthcare Pharmaceuticals INC. | $21.29 | 2023 | |
| Medtronic, INC. | $19.13 | 2023 | Rapidvac |
| Aveo Pharmaceuticals, INC. | $18.85 | 2023 | Fotivda |
| Eisai INC. | $18.65 | 2024 | |
| Astellas Pharma US INC | $15.52 | 2019 | |
| Puma Biotechnology, INC. | $14.28 | 2020 | |
| Pfizer INC. | $13.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.